UnknownNot Applicable

CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction

150 participantsStarted 2021-01-31

Plain-language summary

According to french recommandations for IUGR management we have to propose a CGH-array analysis if the IUGR is severe (bellow the 3rd percentile) and early (in the second trimester). However there is no data to support this point of view.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * pregnant women * fetus with an isolated intra-uterine growth restriction (IUGR) severe (bellow the third percentile on CFEF curves) and early (between 21 and 24 gestational weeks). Exclusion Criteria: * associated IUGR (with other abnormalities during prenatal screening)

What they're measuring

rate of abnormal CGH-array in the groupe "severe and early" UGR

Timeframe: one-time (at the time of the analysis)

Trial details

NCT IDNCT04729361

SponsorCentral Hospital, Nancy, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-03-15

View on ClinicalTrials.gov More IUGR trials